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The pattern of metabolism by early embryos in vitro has been linked to a range of 
phenotypes, including viability.  However, the extent to which metabolic function of 
embryos is modified by specific methods used during ART has yet to be fully described.  
This study has sought to determine if the mode of fertilization used to create embryos 
affects subsequent embryo metabolism of substrates.  A metabolic profile, including 
consumption of key substrates and the endogenous triglyceride content of individual 
IVF and ICSI supernumerary embryos, was assessed and compared. Embryo 
development and quality was also recorded.  All embryos were donated at a single 
clinical IVF centre, on day 5, from 36 patients aged 18-38 years, The data revealed 
that consumption of glucose and pyruvate, and production of lactate, did not differ 
between embryos created by IVF or ICSI. Similarly, the mode of insemination did not 
impact on the triglyceride content of embryos. However, ICSI-derived embryos 
displayed a more active turnover of amino acids (p=0.023), compared to IVF embryos. 
The specific amino acids produced in higher quantities from ICSI compared to IVF 
embryos were aspartate (p=0.016), asparagine (p=0.04), histidine (p=0.021), and 
threonine (p=0.009) while leucine consumption was significantly lower (p=0.04). 
However, importantly neither individual nor collective differences in amino acid 
metabolism were apparent for sibling oocytes subjected to either mode of fertilisation. 
Embryo morphology (the number of top grade embryos) and development (proportion 
reaching the blastocyst stage) were comparable in patients undergoing IVF and ICSI. 
In conclusion, the microinjection of spermatozoa into oocytes does not appear to have 
an impact on subsequent metabolism and viability. Observed differences in amino acid 
metabolism may be attributed to male factor infertility of the patients rather than the 
ICSI procedure per se.  
 





Since the first live birth following IVF in 1978, over 8 million children have been 
conceived using ART (De Geyter, 2018) The introduction of ICSI in 1992 (Palermo et 
al., 1992) has in part contributed to this rise, since it revolutionized the treatment of 
male factor infertility.  Worldwide, approximately two-thirds of all ART procedures 
performed involved ICSI and use has risen in recent years (Dieke et al., 2018), 
regardless of the etiology of infertility (Nyboe Andersen et al., 2008; Dieke et al., 2018). 
It has been proposed that ICSI may be beneficial even in cases when no male factor 
is involved in order to avoid unanticipated failed fertilization, which occurs in an 
estimated 10% of IVF cycles (Staessen et al., 1999; Komsky-Elbaz et al., 2013).  
 
Higher fertilization rates have been reported for ICSI compared to IVF, when 
comparing sibling oocytes and normozoospermic samples (Komsky-Elbaz et al., 2013) 
and one study has reported that the proportion of ICSI embryos reaching the 4-cell 
stage at 42 hours post insemination is significantly higher than that from IVF (Staessen 
et al., 1999). However, studies have failed to identify any significant impact of either 
mode of insemination on embryo quality, as assessed using conventional 
morphological, cleavage stage grading techniques (Calderon et al., 1995; Yang et al., 
1996; Ruiz et al., 1997; Komsky-Elbaz et al., 2013). Despite this, questions remain 
about the safety of the ICSI technique since microinjection and the manipulations 
involved make ICSI significantly more invasive than conventional IVF.  Such in-vitro 
handling techniques reportedly increase the possibility of detrimental epimutations 
(Morgan and Whitelaw, 2008; Rivera et al., 2008).  
 
The ICSI procedure carries several identified risks; there is the possibility of damage 
incurred during the injection process, for example, the risk of disturbing the spindle 
during the introduction of the pipette (Blake et al., 2000; Dumoulin et al., 2001) and the 
risk of injecting foreign contaminants. Moreover, ICSI bypasses the normal 
spermatozoon-oocyte interaction and fusion process since the zona pellucida and 
oolema are selective for binding sperm with normal morphology (Garrett et al., 1997), 
whereas in ICSI any oocyte-led selection of the spermatozoa is bypassed entirely.  In 
addition, in the pig, sperm nuclear decondensation has been shown to be delayed in 
ICSI compared to IVF (Katayama et al., 2002).  One explanation for this may be the 
retention of the acrosome, which may physically disturb sperm chromatin 
decondensation, resulting in asynchronised decondensation of sperm chromosomes 
(Terada et al., 2000). Furthermore, there are reported differences in the pattern of 
calcium-induced transients (Tesarik et al., 2004), replication of the genome and 
positioning of chromosomes (Terada et al., 2000) between ICSI and IVF derived 
zygotes.  
 
A number of studies have reported that children born as a result of ART have increased 
frequencies of a number of disorders of epigenetic aetiology (DeBaun et al., 2003; 
Maher et al., 2003; Moll et al., 2003; Halliday et al., 2004). Studies specifically 
comparing malformation rates in IVF and ICSI conceived children have thus far been 
inconclusive, although recent evidence hints that males born from ICSI might have 
depressed sperm counts (Belva et al., 2016). Some reports have suggested that ICSI 
births are more likely to be associated with imprinting errors leading to disorders such 
as Beckwith-Wiedemann syndrome and Angelmann syndrome (Aytoz et al., 1998; Cox 
et al., 2002). However, meta-analyses comparing malformation rates in infants 
conceived naturally and through IVF or ICSI have failed to reach a satisfactory 
consensus. The lack of an appropriate control group means that it has not been 
possible to determine if the risks are due to the influence of infertility per se or the 
specific interventions used in ART (Rimm et al., 2004).  
 
Studies on individual supernumerary embryos generated from IVF and ICSI patients 
have also informed the debate surrounding the safety of these techniques. Thus, 
Munne et al (1998), reported no differences between rates of chromosome 
abnormalities from IVF and ICSI embryos. Likewise, Santos et al (Santos et al., 2010) 
concluded that ICSI does not lead to an increased incidence of epigenetic errors. 
However, in a murine model using sibling oocytes fertilized by IVF or ICSI, Bridges et 
al (2011) observed significant differences in the expression of a number of genes which 
regulate metabolic pathways, including cholesterol and lipid metabolism/ catabolism. 
 
Embryo metabolism may provide an objective biomarker of human embryo physiology, 
and techniques are available to examine the depletion of glucose and pyruvate and 
appearance of lactate, the turnover of amino acids, and the total content of triglyceride 
within single human embryos. Compelling evidence has indicated that the 
consumption and release of metabolites into embryo culture medium can serve as a 
quantifiable means of assessing embryo quality (Houghton et al., 2002; Brison et al., 
2004; Sturmey et al., 2010; Gardner et al., 2011). Collectively, these data indicate that 
during each development stage there are upper and lower values of metabolic 
normality, outside which embryos show a decline in viability (Gardner et al., 2011; 
Guerif et al., 2013), a concept described as the “Goldilocks Zone” by Leese et al 
(2016). Comparable data from animal studies (Rivera et al., 2008; Sturmey et al., 2010; 
Van Hoeck et al., 2011; Guerif et al., 2013) indicate that early embryo metabolism 
impacts on the physiology and health of the early embryo, in a way which might persist 
into adulthood, and it is therefore vital to determine the effect in human embryos. 
However, to date, the impact of IVF and ICSI techniques on embryo metabolism in 
humans has not been evaluated directly.  Uppangala et al (2016) described differences 
in amino acid metabolism between embryos derived from parents with infertility 
ascribed to male factor, compared to embryos from cases of tubal-factor infertility.  
However, the potentially critical role of insemination technique on embryo metabolism, 
which impacts on the success of pregnancy and health of the offspring, has yet to be 
explored. 
 
In this study we have used a range of quantitative metabolic assessments to compare 
the phenotype and viability of individual human embryos produced by IVF with those 
derived through ICSI. Importantly, we have analysed data from couples undergoing a 
split IVF/ICSI treatment cycle.  Such approaches provide the opportunity to determine 
if embryo metabolism is linked to the mode of insemination or relates to the severity of 
male factor infertility of the patients treated.  
Material and Methods 
 
Patient selection and embryo source 
All research was carried out according to licence conditions of the Human Fertilisation 
and Embryology Authority (Licence R0067), with full ethical approval (09/HI304/44). 
All patients indicating a willingness to be approached about research were given the 
opportunity to participate in the study. Twenty-nine consecutive patients presenting for 
ART at the Hull IVF Unit donated a total of 150 embryos with full informed consent. In 
this cohort there were 91 IVF and 59 ICSI embryos (study group A). During the course 
of further study, a small number of patients who had borderline ‘normal’ semen 
evaluations had elected to undergo split IVF/ICSI treatment and all such patients willing 
to participate in research were included in the study.  This led to an additional seven 
patients who donated 26 embryos that had been generated from IVF and 24 produced 
by ICSI after sibling oocytes had been randomly assignment to a treatment group 
(study group B). 
 
Patient data available from routine clinical investigation included a description of the 
cause of infertility, hormonal profile and antral follicle counts as well as details of the 
treatment, including the number and quality of eggs retrieved, rates of fertilisation and 
embryo development, pregnancy and miscarriage. 
 
Ovarian stimulation and oocyte collection were performed as described in Dickerson 
et al ( 2010).  Oocytes were cultured at 370C in 6%CO2/5%O2, in Sage Fertilisation 
Medium (Cooper Surgical, Trumball, CT, USA). Oocytes were fertilised by 
conventional IVF or ICSI on the basis of semen quality in accordance with the World 
Health Organization (WHO) guidelines (World Health Organisation, 2010). In cases of 
a ‘borderline’ normal semen result, sibling oocytes were assigned randomly to IVF or 
ICSI treatment; both procedures were performed simultaneously within 5 hours after 
retrieval. A semen result was classified as ‘borderline’, if at least one of the individual 
parameters was below the WHO reference value, but within the calculated uncertainty 
of measurement for the laboratory, as per ISO15189 sample reporting requirements. 
Embryos were cultured in groups until day 3 in 1ml droplets of Sage Cleavage medium 
and in Sage Blastocyst medium (Cooper Surgical) until day 5. One embryo was 
transferred to the patient on day 5.  
 
Research embryo culture and assessment 
Surplus embryos that on the afternoon of day 5 were not suitable for transfer or 
cryopreservation were donated to research, with full patient consent.  All reagents were 
sourced from Sigma Aldrich, (Poole, UK) unless stated otherwise.  Stage of 
development was recorded and embryos placed individually into 5µL droplets of culture 
medium specifically validated for use with metabolic assays; an Earl’s balanced salt 
solution, supplemented with 0.5%(v/v) human serum albumin, 1mM glucose, 0.47mM 
pyruvate, 5mM Lactate and a physiological mixture of amino acids (Houghton et al., 
2002). Embryos were cultured under oil at 37oC in 6%CO2/5%O2, for 19-24-hours 
alongside embryo-free control drops. Culture media was refreshed every 24 hours and 
stage of embryo development and quality was recorded.  As observations were taken 
across a period of 24h, the day that observation started was used to describe embryos. 
Embryos that had failed to form a blastocyst, but continued to develop and undergo 
cell division were classified as slow developing, whereas those that reached the 
blastocyst stage were classified according to their degree of expansion, according to 
European consensus (Balaban et al., 2011). An embryo that failed to change in 
development stage after 48-hours in culture was classified as arrested.  Observations 
were continued until day 8, or developmental arrest, to permit data capture from slower 
developing embryos. After each period of 19-24 hours incubation, the spent culture 
medium was frozen immediately at -800C for subsequent metabolic analysis (Fig. 1). 
 
Metabolic profiling  
Metabolic profiles were determined by measuring the depletion and appearance of 
glucose, pyruvate, lactate and 18 amino acids, according to established techniques 
that may be applied to individual oocytes and embryos (Guerif et al., 2013) and provide 
quantitative markers of embryo health.  
Depletion of glucose and pyruvate consumption and accumulation of lactate were 
measured using ultramicrofluorometric assays, as described in Leese and Barton, 
(1984) and modified by Guerif et al., (2013). Some of the sample medium (1µl) was 
added to 10µl of assay mixture. Uptake or production measurements were determined 
in triplicate for standards and control droplets, however single measurements were 
taken from test droplets to maximize the number of assays that could be performed 
simultaneously.  
A coupled colorimetric assay, as described in Sturmey and Leese (2003), was used to 
measure the triglyceride content of groups of 2-5 embryos that had reached equivalent 
development stages for each patient at the end of the culture period.  Analysis of 
pooled embryos was necessary to overcome the limits of sensitivity of the assay, and 
thus data points for individual embryos are not shown for these assays. 
Amino acid concentrations in spent culture droplets were determined using reverse-
phase high performance liquid chromatography (HPLC), as described in Sturmey et 
al., (2009), using an Agilent 1100 HPLC system (Agilent Technologies, Stockport, UK).  
Briefly, 2µl of sample was diluted 1:12:5 in HPLC grade water. Amino acid 
concentrations were determined by analyzing area under the curve of individual peaks, 
which were then normalised to a non-metabolisable internal standard.  Mean sums of 
amino acid production and depletion were expressed in pmol per embryo per hour for 
day 5 to 8 of culture. Results were recorded according to stage reached at the end of 
the period of culture.  
 
All values for substrate depletion/appearance are expressed as pmol per embryo per 
hour.  This was calculated by subtracting the amount of a given substrate in the embryo 
droplet from that of the undisturbed medium controls. Where the concentration of a 
substrate was lower in the embryo droplet than the control, a negative value was 
recorded and this was assumed to represent depletion; where the concentration in the 
embryo droplet was greater than that of the control, a positive value was indicated and 
this was assumed to represent release from the embryo into the medium.  The 
difference from control values was then divided by the precise duration of culture in 
hours i.e. afternoon of day 5- 6 (i.e. Day 5) approximately 19 hours; day 6-7 (i.e. Day 




The data from the metabolic profiling of spare embryos was compared between IVF 
and ICSI embryos and correlated retrospectively to embryo developmental progress.  
Data are expressed as pmol per embryo per hour (pmol/e/h).  Analyses were 
performed using GraphPad Prism 8 (GraphPad, San Diego, CA, USA) for macOS and 
IBM SPSS (V5; IBM Porstmouth, UK).  Power calculations were performed using the 
Birkett and Day Method (Birkett and Day, n.d.) and studies were designed to achieve 
80% power, unless stated otherwise.  Based on previous validation studies, the 
expected blastocyst development rate for supernumerary research embryos is 30% 
(12) and therefore a minimum of 56 embryos would be required in each group for 0.8 
Power to be achieved.  Levene’s test for normality was performed and parametric/non-
parametric methodology was used as indicated.  A p-value of <0.05 was considered 
significant. 
 
Univariate regression analysis was used to compare continuous data, while 
independent sample Student’s t-test or Mann Whitney U test were used to compare 
grouped two-sample data. Intra- and inter-patient variability within the embryo cohort 
were assessed by ANOVA in combination with multiple log-linear regression analysis, 
with Holms test (if F<0.05) to assess the predictive accuracy of metabolic profile on 
blastocyst development rate.  Kruskal-Wallace H test was used when data exhibited 
significant variance in homogeneity and was used to compare metabolic profile 
differences between IVF and ICSI embryos, with post-hoc testing (Duncan’s test) if the 
necessary level of statistical significance was achieved.  Principal component analysis 
(PCA) was used to reduce the dimensionality of the individual 18 amino acid 
measurements and adjust for multiple testing. 
Results 
 
Study group A – exclusive IVF or ICSI treatment  
In study group A, 58.6% of patients had embryos fertilized by gamete co-incubation 
(n=17, 91 embryos) and 41.4% had ICSI treatment (n=12, 59 embryos). There were 
no significant differences between the patient age, BMI, ovarian response, embryo 
development and implantation.  Semen parameters were, however, significantly poorer 
for the ICSI patient group (Table I; p<0.01).   There was no significant difference in 
blastocyst formation between the groups; 42.9% by day 7 in the IVF group compared 
to 32.2% from the ICSI group (p=0.23).   
 
Glucose, lactate and pyruvate 
In total, 150 embryos were assayed for glucose and pyruvate metabolism and lactate 
production.  Figure 2 shows that uptake of glucose and pyruvate did not differ 
according to the method of insemination. Glucose consumption was 101.6 and 83.1, 
and pyruvate consumption was 33.6 and 31.2pmol/e/h for IVF and ICSI embryos, 
respectively. There were also no differences in lactate production (107.8 versus 
108.8pmol/e/h for IVF and ICSI embryos, respectively).  
 
Mean glucose consumption of all embryos fell from 115.8pmol/e/h on day 5 to 
76.05pmol/e/h on day 7; lactate production fell from 114.2 to 90.97pmol/e/h and 
pyruvate consumption remained relatively stable, at between 30.05 and 
30.42pmol/e/h, during the period of culture analysis. However, embryos reached the 
blastocyst stage on different days in culture and the corresponding results displayed a 
wide range in values.  Importantly, when values were evaluated according to stage of 
development the variation in glucose consumption was reduced dramatically (Table 
II); embryos at corresponding stages of development had comparable metabolic 
profiles in the IVF and ICSI cohorts (ANOVA p>0.05). Furthermore, this was 
independent of grade and the day of development (as determined by one-sample, 2 
tail Kolmogorov-Smimov test p>0.05).   
 
There were no significant differences in the kinetics of IVF and ICSI embryos; during 
the 5-7 days of extended culture 43% (39/91) of IVF embryos continued developing to 
reach the blastocyst stage, compared to 32% (19/59) of ICSI embryos (p=0.23). The 
mean glucose consumption for developing blastocysts was 103.5 (±9.9) (±SEM) and 
106.9 (±15.4) for IVF and ICSI embryos, respectively (p=0.85). The values for IVF and 
ICSI embryos, respectively, for pyruvate consumption were 33.8 (±3.3) pmol/e/h and 
30.9 (±4.8) (p=0.63) pmol/e/h, and for lactate production were 104.6 (±12.1) pmol/e/h 
and 105.3 ± (15.9) pmol/e/h (p=0.97). The glycolytic rate was comparable for 
blastocysts derived from IVF and ICSI embryos.  
 
Multiple logistic regression was used to evaluate the statistical significance of each 
independent variable to predict blastocyst development and account for possible inter- 
and intra-patient variability. The mode of fertilization did not influence the probability of 
continued blastocyst development (odds ratio 1.77 (0.85-3.4)). Glucose uptake was a 
significant predictor variable (odds ratio 1.02 (1.01-1.02)). Embryos consuming higher 
quantities of glucose were more likely to form full blastocysts.   
 
Amino acids 
We next examined the amino acid profile of ICSI and IVF embryos and found that ICSI 
embryos produced significantly more amino acids than IVF-generated embryos 
(p=0.023; Fig. 3A). Multivariate analysis was used to determine the specific amino 
acids produced in higher quantities by ICSI embryos, which were; aspartate (0.29 for 
ICSI and 0.17pmol/e/h for IVF; p=0.016), asparagine (0.23 and 0.04 pmol/e/h 
respectively; p=0.04), histidine (0.55 and 0.22 pmol/e/h; p=0.021), and threonine (0.41 
and 0.17 pmol/e/h; p=0.009). The consumption of leucine was significantly lower (0.01 
for ICSI and 0.23 pmol/e/h for IVF; p= 0.04) in ICSI than IVF embryos.  
 
Given the observed differences in amino acid profiles between embryos from patients 
receiving ICSI versus the IVF counterparts, we further examined the net rates of 
depletion or appearance of amino acids  dependent on the stage of development 
attained using multiple log-linear regression (Fig. 3B). Despite there being no 
significant differences in blastocyst development rates between IVF and ICSI derived 
embryos, there was a trend for higher rates of early arrest in the ICSI population. 
Nineteen of the 91 IVF embryos arrested at the cleavage stage, compared to 24 of the 
59 ICSI embryos, and the mean amino acid turnover for these embryos was 1.32 (±0.7) 
pmol/e/h and 5.45 (±1.8) pmol/e/h respectively (p=0.07). Comparatively, 30 IVF 
embryos reached full or hatched blastocyst stage and 17 ICSI embryos, with mean 
amino acid turn over rates of -0.48 (±0.2) pmol/e/h and -0.70 (±0.3) pmol/e/h, 
respectively (p=0.5). At each individual development stage there were no significant 
differences in the turnover of amino acids for IVF versus ICSI derived embryos.   
 
Overall, embryos which arrested at the earlier stages of development had a higher 
turnover of amino acids; specifically asparagine (0.19 compared to -0.01pmol/e/h; 
p=0.002), aspartate (0.25 and 0.16 pmol/e/h; p=0.01) and glutamate (0.44 and 0.26 
pmol/e/h; p=0.001) were consumed in significantly higher quantities by those arresting, 
and alanine production was greater (1.35 and 1.25 pmol/e/h; p=0.02) compared to 
those that formed blastocysts. Those embryos that developed beyond the unexpanded 
blastocyst stage produced significantly lower quantities of amino acids, but 
consumption of methionine was significantly higher in developing blastocysts (0.18 and 
0.06 pmol/e/h; p=0.001), as was arginine (0.79 and 0.68 pmol/e/h; p=0.003), and 
histidine production was high in expanded and hatched blastocysts (0.38 and 0.28 
pmol/e/h, respectively ;p=0.01). 
 
The data from the 18 amino acids were transformed by PCA, as it is likely that 
differences in the consumption and release of individual amino acids may be related.  
Therefore, prior to further multivariate testing, the variance for each of the 18 individual 
amino acids was used to create a smaller set of linear combinations. The data were 
transformed with five eigenvectors, accounting for 69% of the total variance. A three-
component solution explains 54.9% of the data and is presented in Fig. 3C. 
Component 1 (PC1) accounted for 36% of the variance and the majority of the amino 
acids included in PC1 are neutral and polar and appear to belong to system N 
transporters. After the PC adjustment for covariation, a permutated-based adjustment 
of p values was undertaken – only histidine production significantly differed (p<0.05) 
between developing blastocysts generated through IVF and ICSI.  
 
Triglyceride 
Reassuringly, the mode of insemination did not impact on the triglyceride content of 
embryos (Fig. 4A). However, by day 7 of development, striking differences were 
observed in the triglyceride content of embryos reaching the blastocyst stage 
compared to those undergoing early cleavage stage arrest (6.7ng versus 11.32ng 
respectively; p<0.001). Blastocysts generated through both ICSI and IVF contained 
significantly less triglyceride than their cleavage stage arrested counterparts (Fig. 4B).  
 
Study group B; IVF/ICSI sibling embryos 
To understand more about the possible impact that the injection procedure could have 
on subsequent embryo metabolism, 50 sibling embryos derived by IVF or ICSI were 
compared. Blastocyst development rates were comparable (p=0.11), as were rates of 
uptake and production of glucose (p=0.47), lactate (p=0.75) and pyruvate (p=0.93) for 
IVF and ICSI embryos (Fig. 5A). Similarly, there were no significant differences in the 
triglyceride content of ICSI and IVF sibling embryos (Fig. 5C). 
 
Amino acids 
Individual and collective differences in amino acids were not apparent for sibling 
embryos created by IVF or ICSI (Fig. 5B). Interestingly, amino acid turnover was higher 
for IVF embryos in group B patients who had borderline suboptimal semen parameters, 
compared to embryos generated via IVF in group A patients, who had normal semen 
parameters (0.30 versus 0.83 pmol/e/h for group A and B, respectively) and, 
conversely, amino acid turn over was lower for ICSI embryos in group B (borderline 
suboptimal semen evaluation) compared to group A patients (abnormal semen 




A number of studies have now been published identifying a higher incidence of rare 
imprinting disorders in children born following ICSI treatment (Vermeiden and 
Bernardus, 2013; Lazaraviciute et al., 2014; Uk et al., 2018). In addition, animal studies 
have shown significant differences in the expression of genes which regulate metabolic 
pathways, including cholesterol and lipid metabolism/catabolism in embryos derived 
from IVF and ICSI (Sanchez-Calabuig et al., 2014). We therefore set out to discover if 
the early stages of development, from cleavage divisions to blastocyst formation, and 
the corresponding processes of embryo metabolism are perturbed in embryos 
produced by ICSI.  In this study, we have shown that embryo morphology (the number 
of top grade embryos) and development (proportion reaching the blastocyst stage) 
were comparable in patients undergoing IVF and ICSI. This is consistent with the 
previously reported findings of Plachot et al ( 2002) and Fishel et al ( 2000), but 
contrary to the findings of Griffiths et al ( 2000) who reported that blastocyst 
development rates were compromised by the ICSI procedure. Such studies have given 
inconsistent results and the subjective nature of embryo grading schemes challenges 
the validity of the conclusions that can be reached. By contrast, the use of metabolic 
biomarkers enables quantitative comparisons of embryo physiology and viability to be 
made.    
 
The metabolism of substrates is indicative of embryo developmental progress, with 
embryos developing to blastocysts having higher glycolytic activity and a lower 
triglyceride content than those arresting at the early stages of development (Gardner 
et al., 2011; Leary et al., 2015). The data presented in this analysis illustrate an altered 
amino acid metabolism at each developmental stage. Reassuringly the data presented 
show that the method of fertilization had a only limited impact on the developmental 
stage specific utilization of substrates.   
 
Our data revealed that glucose and pyruvate depletion and lactate release into the 
medium did not differ according to the mode of fertilization.  Moreover, levels of 
endogenous triglyceride were not influenced by mode of fertilization.  However, when 
we compared embryos from patients undergoing IVF with those having an ICSI cycle, 
we observed significant differences in overall amino acid profile.  Embryos from 
couples undergoing ICSI had a higher overall amino acid metabolism, despite there 
being no significant differences in development stage attained for embryos in each 
group.  Increased amino acid turnover by embryos has previously been associated 
with sub-optimal embryo viability (Houghton et al., 2002; Brison et al., 2004; Picton et 
al., 2010).  Indeed, our own data here support the notion that amino acid profile differs 
significantly between embryos that develop and those which arrest.  Notably, once 
results had been corrected to control for confounding variables and adjusted for 
multiple testing, histidine was produced in higher quantities from ICSI-generated 
embryos. Histidine is transported by a system N mechanism of amino acid transport, 
a Na+-dependent channel that is mostly expressed in the central nervous system.  The 
significance of this finding is not clear, especially since histidine handling has not 
previously been reported to differ between viable and non-viable human embryos 
(Houghton et al., 2002; Brison et al., 2004; Picton et al., 2010), although it does differ 
between in vivo derived cattle embryos and those created by IVF (Sturmey et al., 
2010). 
 
As we were unable to conclude from this data set whether it was the mode of 
fertilisation that caused a difference in metabolism, or whether the origin of these 
differences was a feature of the cause of infertility, we compared the impact of the 
mode of fertilsation on the metabolism of sibling oocytes using semen from men with 
mild factor male infertility (study group B).  In this analysis, there were no significant 
differences in the metabolic utilization and fate of glucose, lactate and pyruvate.  
Triglyceride levels were comparable in stage-equivalent embryos. Importantly, the 
observed differences in amino acid turnover were no longer apparent and likewise 
there were no significant differences in any of the 18 individual amino acids. Amino 
acid turnover was marginally higher for IVF derived embryos created in group B than 
IVF embryos from group A; the difference being that in group B patients semen 
parameters were in the borderline normal/abnormal range. One plausible explanation 
for the general rise in amino acid turnover for embryos generated from poorer quality 
semen samples may be related to higher levels of molecular damage. A higher 
incidence of numerical and structural chromosome aberrations is associated with 
suboptimal semen parameters (Sakkas et al., 2002). Metabolic activity has been 
correlated with molecular damage; embryos with lower levels of damage have 
characteristically low metabolic activity (Sturmey et al., 2009). This finding would seem 
to suggest that the differences identified in group A between IVF and ICSI embryos 
could be attributed to the underlying andrological infertility. It is thus plausible that the 
underlying male infertility and any sperm DNA damage is promutagenic and may 
introduce mutations that become fixed in the germline (Cox et al., 2002).   
 
 
The main limitation of this study is that adverse effects of fertilization route may not 
manifest at cleavage and blastocyst stage. Implantation is a test of embryo viability; 
however the metabolic studies were performed on poorer quality sibling embryos that 
were not suitable for transfer or cryopreservation. In addition, it may well be that any 
metabolic differences between IVF and ICSI conceived populations do not become 
apparent until organ morphogenesis is complete. Some degree of assurance is 
granted by the finding that rates of spontaneous abortions are comparable for IVF and 
ICSI conceptions (Bettio et al., 2008). In addition, studies comparing ICSI children with 
the general population have reported no differences in development, growth, weight, 
height, head circumference and pubertal staging (Belva et al., 2008, 2011; 
Wennerholm et al., 2009).  Likewise, there are no reported differences in cognitive and 
motor development between IVF and ICSI conceived children (Rimm et al., 2004; 
Bonduelle et al., 2005). The caveat of these reports is that many of the studies have a 
high incidence of patients lost to follow-up. 
 
In conclusion the data presented provide assurances about the ICSI procedure, 
however the aim of any reproductive intervention should be to use the simplest, least 
expensive procedure, with the greatest chance of producing healthy children (Barker 
et al., 1993). It would therefore seem reasonable to suggest that ICSI should be 
reserved for male factor cases of infertility. The microinjection of spermatozoa into 
oocytes does not significantly impact on the metabolism and viability embryos. 
However, andrological infertility of the patients rather than the ICSI procedure per se 
may lead to minor alterations of embryo metabolism post fertilisation.  
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Figure 1 Overview of study design depicting patient, embryo and sample utilization.  
HPLC: high performance liquid chromatography  
 
Figure 2 The depletion and release of glucose, pyruvate and lactate by IVF (n=91) 
and ICSI-derived (n=59) embryos between days 5 and 7 of culture. 
Data are expressed as pmol/embryo/hr.  
 
Figure 3 The effect of mode of fertilization on amino acid metabolism by single 
human embryos.  (A) The sum of mean amino acid production and depletion, 
expressed in pmol/embryo/hour for IVF and ICSI-derived embryos between day 5 to 7 
of culture. Results are recorded according to IVF (n=91) and ICSI (n=59). Significantly 
lower production and depletion of amino acids was evident for IVF embryos, p<0.05 
(Mann Whitney U Test) Error bars represent 95% CI. (B) Significant differences in 
amino acid turnover were evident between those failing to form blastocysts and those 
blastocysts that were able to complete (n= 43 cleavage stage, 48 morula, 11 early, 22 
full and 25 hatched). Error bars represent 95% CI, *p<0.05.  (C) PC used for all 18 
amino acids per embryo for developing blastocysts to identify outlying amino acids and 
determine differences in IVF (n=39) and ICSI (n=19) populations. Principal component 
(PC) plot in rotated space- rotation converged in 11 iterations (PC1; trp, glu, asp, gly, 
thr, gln,tyr, ser, asn, his, lys). (D) Only histidine is significantly different when PC1 
components are separated into IVF and ICSI cohorts. The suitability of the data for this 
type of analysis was confirmed; standards met = Kiaser-Meyer-Olkin Measrue of 
Sample Adequacy (KMO)= 0.77, Bartlett’s test 0.000). 
 
Figure 4 Mode of fertilization does not affect mean triglyceride content of 
human embryos. 
(A) Mean triglyceride (TG) content of embryos fertilized by IVF (n=86) or ICSI on day 
7 (n=54), expressed as ng/embryo.  (B) TG content of embryos according to 
development stage attained for ICSI and IVF generated embryos n= 34 developed 
IVF and 52 arrested; n= 18 developed ICSI and 36 arrested embryos on day 7. Error 
bars represent 95% CI,  **p<0.01*** p<0.001 (Mann Whitney U Test). (Note- no 
sample results possible for 10 embryos, as samples perished during this analysis) 
 
Figure 5 Metabolic profile of sibling embryos does not appear to be influences by mode 
of fertilization. 
(A) Mean glucose and pyruvate uptake and lactate production between days 5 and 7 
of culture, expressed as pmol/embryo/h for sibling embryos derived by IVF (n=26) or 
ICSI (n=24). (B) Mean sums of amino acid production and depletion, day 5-7; 
comparable for sibling embryos (p=0.39). (C) TG content on day 7 for sibling embryos 
derived by IVF (n=21) or ICSI (n=22) (no sample results possible for TG analysis for 
n=5 IVF and n= 2 ICSI). 
.  
 
Table I Patient demographics for each treatment group are comparable, with the 













Female age years 34.67 (0.99) 32.91 (1.44)  0.31 
Female BMI m/kg2 22.89 (0.99) 23.65 (0.94)  0.6 
Anti-Mullerian hormone pmol/l 20.66 (4.32) 20.89 (3.75)  0.97 
no. oocytes 9.6 (0.98) 9.91 (0.83)  0.82 
Male age years 36.33 (1.26) 38.73 (2.12)  0.31 
Male BMI m/kg2 26.77 (0.86) 24.42 (0.86)  0.07 
Sperm concentration M/ml 77.04 (14.93) 18.42 (5.11)  <0.01 
Sperm motility % 67.0 (2.97) 40.91 (4.37)  <0.001 
Sperm morphology % 7.20 (0.34) 3.73 (0.45)  <0.001 
no. fertilised oocytes 7.0 (0.94) 6.0 (0.38)  0.39 
no. top grade embryos 3.73 (0.71) 3.0 (0.56)  0.73 
no. blastocysts 1.67 (0.37) 1.64 (0.39)  0.96 
Clinical pregnancy rate % 10/17 58.8 3/12 25  0.13 
Live birth rate % 10/17 58.8 3/12 25  0.13 
Gestation (weeks) 39.6 (0.57) 40.5 (0.5)  0.59 
Birthweight (g) 3244.7 (231.5) 3620.0 (220.0)  0.46 
* Student’s t-test, and Fishers exact test.   
  
 
Table II Mean metabolite consumption/release according to development stage 
attained for 91 IVF and 59 ICSI embryos.  
 IVF mean (SEM)* ICSI mean (SEM)* 
n Glucose Lactate Pyruvate  n Glucose Lactate Pyruvate 
 




























































* all presented as pmol/embryo/h.  There were no significant differences between 













Figure 1 Overview of study design depicting patient, embryo and sample utilization.  























Figure 2 The depletion and release of glucose, pyruvate and lactate by IVF (n=91) 
and ICSI-derived (n=59) embryos between days 5 and 7 of culture. 












































































































Figure 3 The effect of mode of fertilization on amino acid metabolism by single 
human embryos.  (A) The sum of mean amino acid production and depletion, 
expressed in pmol/embryo/hour for IVF and ICSI-derived embryos between day 5 to 7 
of culture. Results are recorded according to IVF (n=91) and ICSI (n=59). Significantly 
lower production and depletion of amino acids was evident for IVF embryos, p<0.05 
(Mann Whitney U Test) Error bars represent 95% CI. (B) Significant differences in 
amino acid turnover were evident between those failing to form blastocysts and those 
blastocysts that were able to complete (n= 43 cleavage stage, 48 morula, 11 early, 22 
full and 25 hatched). Error bars represent 95% CI, *p<0.05.  (C) PC used for all 18 


































































































determine differences in IVF (n=39) and ICSI (n=19) populations. Principal component 
(PC) plot in rotated space- rotation converged in 11 iterations (PC1; trp, glu, asp, gly, 
thr, gln,tyr, ser, asn, his, lys). (D) Only histidine is significantly different when PC1 
components are separated into IVF and ICSI cohorts. The suitability of the data for this 
type of analysis was confirmed; standards met = Kiaser-Meyer-Olkin Measrue of 































































































Figure 4 Mode of fertilization does not affect mean triglyceride content of 
human embryos. 
(A) Mean triglyceride (TG) content of embryos fertilized by IVF (n=86) or ICSI on day 
7 (n=54), expressed as ng/embryo.  (B) TG content of embryos according to 
development stage attained for ICSI and IVF generated embryos n= 34 developed 
IVF and 52 arrested; n= 18 developed ICSI and 36 arrested embryos on day 7. Error 
bars represent 95% CI,  **p<0.01*** p<0.001 (Mann Whitney U Test). (Note- no 



















































Figure 5 Metabolic profile of sibling embryos does not appear to be influences by mode 
of fertilization. 
(A) Mean glucose and pyruvate uptake and lactate production between days 5 and 7 
of culture, expressed as pmol/embryo/h for sibling embryos derived by IVF (n=26) or 
ICSI (n=24). (B) Mean sums of amino acid production and depletion, day 5-7; 
comparable for sibling embryos (p=0.39). (C) TG content on day 7 for sibling embryos 
derived by IVF (n=21) or ICSI (n=22) (no sample results possible for TG analysis for 
n=5 IVF and n= 2 ICSI). 
 
